Is protease inhibitor-induced nausea and vomiting attenuated by a peripherally acting , opioid-receptor antagonist in a rat model?
These results suggest that methylnaltrexone may have potential clinical utility in reducing nausea and vomiting in HIV patients who take ritonavir.
A recently described yeast-based screening allowed us to identify new Hh/Gli target genes, functionally important in different contexts of vertebrate embryonic development.